A Phase 1 Study of Roxadustat in Subjects With Different Degrees of Renal Function

Clinical trial NCT02965040 · COMPLETED

Trial details

NCT number: NCT02965040
Sponsor: Astellas Pharma Europe B.V.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Normal Renal Function Impaired Renal Function

Start date: 2016-12-12
Primary completion: 2017-12-04
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.